Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen
- PMID: 28585679
- DOI: 10.5603/EP.a2017.0038
Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen
Abstract
Introduction: Medullary thyroid cancer (MTC) is a malignancy of the thyroid gland, which derives from parafollicular C cells. Periodic measurement of biochemical markers of MTC remains a crucial part of patient follow-up and disease monitoring. The aim of the study was to compare the diagnostic value of four selected markers - calcitonin (Ct), procalcitonin (PCT), chromogranin A (CgA), and carcinoembryonic antigen (CEA).
Material and methods: Patients with histopathologically confirmed MTC hospitalised in a single department between January 2015 and December 2015 were included in the study. Patients were subdivided into two groups: a remission group and an active disease group, based upon serum markers of MTC and imaging. Levels of Ct, PCT, CgA, and CEA were compared between the groups.
Results: Forty-four patients were included; 20 patients presented active disease and 24 were in remission. All patients with active disease had Ct exceeding the upper limit of normal range (10 pg/mL) - for that threshold the sensitivity was 100.0% and the specificity was 73.9%; for the best-fit threshold of 121.0 pg/mL the specificity was 95.8% with sensitivity 100.0%. There was significant correlation between Ct and PCT - p < 0.000001, r = 0.93. All patients with active disease exceeded the upper limit of the normal range (0.5 ng/mL) - for that threshold the sensitivity was 100.0% and the specificity was 83.3%; for the best-fit threshold of 0.95 ng/mL the specificity was 95.8% with sensitivity 100.0%. In case of CEA for the best-fit threshold of 12.66 ng/mL the specificity was 100.0% with sensitivity 57.9%; for CgA the best-fit threshold was 75.66 ng/mL with specificity 83.3% and sensitivity 75.0%.
Conclusions: Our study confirms that PCT can be considered as an equivalent alternative for measurement of calcitonin. On the other hand, it is also worth noting that MTC can be a rare cause of very high levels of PTC not resulting from infectious diseases. The diagnostic value of CEA and chromogranin A is much lower and can be within the normal range even in patients with advanced, metastatic MTC. They should be used only as accessory markers.
Keywords: calcitonin; carcinoembryonic antigen; chromogranin A; medullary thyroid cancer; procalcitonin.
Similar articles
-
Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers.Int J Biol Markers. 2008 Apr-Jun;23(2):129-31. doi: 10.1177/172460080802300212. Int J Biol Markers. 2008. PMID: 18629788
-
Negative predictive value of procalcitonin in medullary thyroid carcinoma.Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):213-8. doi: 10.1684/abc.2015.1115. Ann Biol Clin (Paris). 2016. PMID: 26806393
-
Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2004-2013. doi: 10.1007/s00259-017-3759-4. Epub 2017 Jun 23. Eur J Nucl Med Mol Imaging. 2017. PMID: 28646462
-
Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.Curr Oncol. 2019 Oct;26(5):338-344. doi: 10.3747/co.26.5539. Epub 2019 Oct 1. Curr Oncol. 2019. PMID: 31708652 Free PMC article. Review.
-
Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.Cochrane Database Syst Rev. 2020 Mar 16;3(3):CD010159. doi: 10.1002/14651858.CD010159.pub2. Cochrane Database Syst Rev. 2020. PMID: 32176812 Free PMC article.
Cited by
-
Diagnostic challenges in calcitonin negative medullary thyroid carcinoma: a systematic review of 101 cases.Gland Surg. 2024 Oct 31;13(10):1785-1804. doi: 10.21037/gs-24-292. Epub 2024 Oct 26. Gland Surg. 2024. PMID: 39544965 Free PMC article. Review.
-
Preventive Potential of Resveratrol in Carcinogen-Induced Rat Thyroid Tumorigenesis.Nutrients. 2018 Feb 28;10(3):279. doi: 10.3390/nu10030279. Nutrients. 2018. PMID: 29495605 Free PMC article.
-
A Proposed Modified Staging System for Medullary Thyroid Cancer: A SEER Analysis With Multicenter Validation.Oncologist. 2024 Jan 5;29(1):e59-e67. doi: 10.1093/oncolo/oyad165. Oncologist. 2024. PMID: 37311049 Free PMC article.
-
[Value of Baseline Calcitonin for Differential Diagnosis of Medullary Thyroid Cancer].Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):432-438. doi: 10.12182/20230160513. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 36949711 Free PMC article. Chinese.
-
Diagnostic tests for medullary thyroid carcinoma: an umbrella review.Endocrine. 2023 Aug;81(2):183-193. doi: 10.1007/s12020-023-03326-6. Epub 2023 Mar 6. Endocrine. 2023. PMID: 36877452 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials